Postpolycythaemic myelofibrosis: frequency and risk factors for this complication in 116 patients
- 1 September 2009
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 146 (5), 504-509
- https://doi.org/10.1111/j.1365-2141.2009.07804.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatmentLeukemia, 2007
- Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosisBlood, 2007
- Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia VeraJournal of Clinical Oncology, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patientsBritish Journal of Haematology, 2002
- Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 YearsAnnals of Internal Medicine, 1995
- Transforming growth factor‐β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblastsBritish Journal of Haematology, 1989
- Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblastsBritish Journal of Haematology, 1988
- Platelet‐derived growth factor is decreased in patients with myeloproliferative disordersAmerican Journal of Hematology, 1988
- Complications and Causes of Death in Polycythaemia VeraActa Medica Scandinavica, 1962